Trial intelligence / Profile preview

Active oxygen toothpaste for reduction of dental plaque and gingivitis

RBR-48mvdxPhase 1Recruiting

Sponsor
Universidade Positivo
Start
Jun 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of hydrogen peroxide, perboric acid, Revamil, xylitol, lactoferrin and 2 more in gingivitis (2 arms), sponsored by Universidade Positivo. Started Jun 2016; status: recruiting.

02

Drugs

hydrogen peroxideperboric acidRevamilxylitollactoferrin
03

Conditions

gingivitis

Beyond the preview

Go deeper on RBR-48mvdx.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-48mvdx.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call